ScholarIQanswers from OpenAlex & ORCID
Laetitia Borsu
ResearcherPublications, citations & collaboration network
Laetitia Borsu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Laetitia Borsu have?
ScholarIQindexed works
Laetitia Borsu has 142 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Laetitia Borsu have?
ScholarIQcitation count
Laetitia Borsu has 30,604 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Laetitia Borsu?
ScholarIQh-index
Laetitia Borsu has an h-index of 29 in OpenAlex.
What is the i10-index of Laetitia Borsu?
ScholarIQi10-index
Laetitia Borsu has an i10-index of 37 in OpenAlex.
What is the ORCID of Laetitia Borsu?
ScholarIQorcid
The ORCID for Laetitia Borsu is on the source record.
What is the OpenAlex record for Laetitia Borsu?
ScholarIQopenalex
The OpenAlex for Laetitia Borsu is on the source record.
What are the most-cited papers on Laetitia Borsu?
ScholarIQmost cited works
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir, Ryma Benayed, Ronak Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M. Devlin, Matthew D. Hellmann, David Barron, Alison M. Schram, Meera Hameed, Snjezana Doğan, Dara S. Ross, Jaclyn F. Hechtman, Deborah F. DeLair, JinJuan Yao, Diana Mandelker, Donavan T. Cheng, Raghu Chandramohan, Abhinita Mohanty, Ryan Ptashkin, Gowtham Jayakumaran, Meera Prasad, Mustafa Syed, Anoop Balakrishnan Rema, Zhen Y. Liu, Khédoudja Nafa, Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
Donavan T. Cheng, Talia Mitchell, Ahmet Zehir, Ronak Shah, Ryma Benayed, Aijazuddin Syed, Raghu Chandramohan, Zhen Yu Liu, Helen Won, Sasinya N. Scott, A. Rose Brannon, Catherine O’Reilly, Justyna Sadowska, Jacklyn Casanova, Angela Yannes, Jaclyn F. Hechtman, JinJuan Yao, Wei Song, Dara S. Ross, Alifya Oultache, Snjezana Doğan, Laetitia Borsu, Meera Hameed, Khédoudja Nafa, Maria E. Arcila, Marc Ladanyi, Michael F. Berger
Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring <i>MET</i> Mutations Causing Exon 14 Skipping
Paul K. Paik, Alexander Drilon, Pang‐Dian Fan, Helena A. Yu, Natasha Rekhtman, Michelle S. Ginsberg, Laetitia Borsu, Nikolaus Schultz, Michael F. Berger, Charles M. Rudin, Marc Ladanyi